Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Patent
1996-11-04
1999-06-08
LeGuyader, John
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
536 231, 536 2431, 435 6, 435 911, 435375, C07H 2104, C12Q 168
Patent
active
059105836
ABSTRACT:
oligonucleotides are useful as antisense oligonucleotides for inhibiting the expression of the ERBB2 tyrosine kinase receptor in a cell, in vitro or in vivo.
REFERENCES:
patent: 5599704 (1997-02-01), Thompson et al.
Vaughn et al., "Antisense DNA downregulation of the ERBB2 oncogene measured by a flow cytometric assay", Proc. Natl. Acad. Sci. USA 92:8338-8342, Aug. 1995.
Mahen et al. Archives of Biochem. & Biophys. 253:214-220, 1987.
Gewirtz et al. PNAS 93:3161-3163 (1996).
Rojanasakul Adv. Arug. Delivery Ruvs. 18(1996) 115-131.
Inglehart James D.
Marks Jeffrey R.
Vaughn James P.
Duke University
LeGuyader John
LandOfFree
Antisense oligonucleotides against ERBB-2 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antisense oligonucleotides against ERBB-2, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antisense oligonucleotides against ERBB-2 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1683962